Skip to Main Content

Paper Details

Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.
Sci Transl Med
23
2021
Author NameAffiliation
Matthew N CooperTelethon Kids Institute, University of Western Australia
Giles W RobinsonSt. Jude Children's Research Hospital
Giles W RobinsonSt. Jude Children's Research Hospital
Stefan M PfisterHopp Children's Cancer Center (KiTZ) and German Cancer Research Center (DKFZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterHopp Children's Cancer Center (KiTZ) and German Cancer Research Center (DKFZ)
Stefan M PfisterHeidelberg University Hospital
Marcel KoolHopp Children's Cancer Center (KiTZ) and German Cancer Research Center (DKFZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolHopp Children's Cancer Center (KiTZ) and German Cancer Research Center (DKFZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Till MildeHopp Children's Cancer Center (KiTZ) and German Cancer Research Center (DKFZ)
Till MildeHeidelberg University Hospital
Amar GajjarSt. Jude Children's Research Hospital
Terrance G JohnsTelethon Kids Institute
Terrance G JohnsUniversity of Western Australia
Robert J Wechsler-ReyaNCI-Designated Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute
Robert J Wechsler-ReyaNCI-Designated Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute
Martine F RousselSt. Jude Children's Research Hospital
Nicholas G GottardoTelethon Kids Institute
Nicholas G GottardoUniversity of Western Australia
Nicholas G GottardoPerth Children's Hospital
  • 1 - 22

Datasets